Clinical Pharmacist Intervention to Reduce Drug-related Readmissions Among Older People
Involving Clinical Pharmacists in Transitional Care to Reduce Drug-related Readmissions Among the Elderly - a Randomized Controlled Trial
Umeå University
700 participants
Sep 19, 2018
INTERVENTIONAL
Conditions
Summary
This randomized controlled trial primarily investigates if a clinical pharmacist intervention can reduce drug-related readmissions among patients \>75 years. The intervention targets the transfer between hospital and primary care. In brief, the intervention includes medical chart reviews and patient interviews during a period of 180 days.
Eligibility
Inclusion Criteria3
- Living at home
- Acutely admitted
- Registered at one of ten pre-specified primary care health centers
Exclusion Criteria3
- Patients unable to communicate or who do not speak Swedish
- Patients scheduled for palliative care
- Patients admitted due to intoxication by alcohol or drug (non prescription)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The intervention includes regular medical chart reviews, multiple patient interviews and, if needed, collaboration with the primary care physician.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03671629